Science Pool

Drug Delivery to the Lungs (DDL) 2023

Date: December 6 – 8

Location: Edinburgh International Conference Centre


Our Senior Director • Business Development, Lynsey Haskayne, and Supervisor • ADQC / Inhalation Development, Fabio Russo, will attend DDL2023 

Evotec excels in challenging oral inhalation and nasal product (OINDP) development, leveraging nanotechnology and therapeutic advantages. Our multidisciplinary teams drive inhaled product development for Phase I to late-stage clinical studies, offering tailored plans and robust strategies. Inhalation Analytics and Material Science ensure quality, supported by specific expertise and an integrated approach.

If you wish to discuss any inhalation development projects with Lynsey and Fabio, fill out the meeting form below or send an email to

Learn more about DDL 2023


December 6 – December 8, 2023


Edinburgh, UK

Arrange a meeting with our scientific experts.
Please enter your details below…

By clicking on ‘Continue’ I agree that my data is being transferred to the Evotec Group. The Evotec Group currently consists of the following companies. For further details please see our Privacy Policy.

If you would like to be kept informed of our latest services, new research, events and other news please tick the box below:

Join our community

Discover the exclusive benefits on offer if you join our Community.